These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 17210685

  • 1. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L.
    Cancer Res; 2007 Jan 01; 67(1):75-84. PubMed ID: 17210685
    [Abstract] [Full Text] [Related]

  • 2. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY, Samarut J, Plateroti M.
    Gastroenterology; 2010 May 01; 138(5):1863-74. PubMed ID: 20114049
    [Abstract] [Full Text] [Related]

  • 3. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 4. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH, Wiese M, Zatula N, Grigoryan T, Dai Y, Fritzmann J, Birchmeier W.
    Gastroenterology; 2011 Oct 15; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [Abstract] [Full Text] [Related]

  • 5. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL.
    Cancer Res; 2005 Mar 15; 65(6):2296-302. PubMed ID: 15781643
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.
    Cancer Res; 2008 Mar 15; 68(6):1809-19. PubMed ID: 18339861
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 15; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 8. TGF beta regulation of cell proliferation.
    Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R.
    Princess Takamatsu Symp; 1994 Jun 15; 24():250-63. PubMed ID: 8983080
    [Abstract] [Full Text] [Related]

  • 9. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

  • 10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.
    Gastroenterology; 2009 Jul 29; 137(1):165-75. PubMed ID: 19328798
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
    Crowley MR, Frost A, Chen DT, Baffi MO, Nicola T, Serra R.
    Differentiation; 2006 Feb 29; 74(1):40-52. PubMed ID: 16466399
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, Moses HL, Grady WM.
    Cancer Res; 2006 Oct 15; 66(20):9837-44. PubMed ID: 17047044
    [Abstract] [Full Text] [Related]

  • 13. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y, Bommer GT, Zhai Y, Akyol A, Hinoi T, Winer I, Lin HV, Cadigan KM, Cho KR, Fearon ER.
    Cancer Res; 2007 Jan 15; 67(2):482-91. PubMed ID: 17234755
    [Abstract] [Full Text] [Related]

  • 14. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM, Shackleford GM.
    Oncogene; 1997 Jun 19; 14(24):2985-9. PubMed ID: 9205106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct 19; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 17. WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.
    Zeilstra J, Joosten SP, Wensveen FM, Dessing MC, Schütze DM, Eldering E, Spaargaren M, Pals ST.
    Biochem Biophys Res Commun; 2011 Mar 04; 406(1):1-6. PubMed ID: 21184732
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.
    Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J, Hilkens J.
    Nat Genet; 2007 Jun 04; 39(6):759-69. PubMed ID: 17468756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.